The observation of EEG abnormalities in some children treated prenatally raises the question of whether mTOR inhibition, particularly when administered late in gestation, can adequately prevent or mitigate the development of epilepsy and other neurological deficits. This evidence concerns the gene MTOR and epilepsy.